Katy Psychiatry
Shopping Cart
Your Cart is Empty
Quantity:
Subtotal
Taxes
Shipping
Total
There was an error with PayPalClick here to try again

For the Health and Well Being of Mind, Body and Spirit
​Psychiatric Services
Spravato (Esketamine) Nasal Spray Treatment
Spravato (Esketamine) Nasal Spray Treatment
What is Spravato?
- Spravato is an FDA-approved prescription medicine, used along with an antidepressant, for treatment-resistant depression (TRD) in adults.
- Spravato is the first and only NMDA receptor antagonist. It works differently than currently available oral antidepressants.
- Greater reduction of depression symptoms at four weeks compared to those who received a placebo plus an oral antidepressant.
How am I considered as a candidate?
- If you have struggled with treatment-resistant depression without adequate relief, schedule a consultation with our clinic to discuss whether Spravato may be an option for you.
Do I need to be referred by a psychiatrist?
- If referred by your psychiatrist, the consultation with be a 30-minute-long visit. Otherwise, the consultation will be an hour long visit to discuss your psychiatric condition and history.
How is it administered?
- Nasal spray you self-administer at a certified Spravato treatment center, under the guidance and supervision of a healthcare professional.
How often will I need to come in for treatment?
- Spravato is taken twice a week for the first four weeks
- After the first four weeks, Spravato is taken once a week for a month
- After this, it is at your health care provider’s discretion
What are other things to keep in mind for the day of treatment?
- Patients should plan for a 2 hour visit and arrange for a ride home.
- You cannot take a benzodiazepine or stimulant medication on the day of treatment.
What are potential side effects from the medication?
- Most side effects are experienced within the treatment session and resolve before discharge. These most commonly include: sedation, disassociation, increased blood pressure. Your vital signs will be measured periodically to ensure your safety.
DO NOT take Spravato if you have:
- Blood vessel disease (aneurysm)
- An abnormal connection between your blood vessels (arteriovenous malformation)
- History of bleeding in the brain
- Allergy to esketamine, ketamine or any of the ingredients in Spravato
- Uncontrolled high blood pressure
- Active substance abuse
- Plans to become pregnant, are pregnant, breastfeeding or planning to breastfeed.
- Please refer to spravato.com for more information. If eligible, please call us to schedule a consultation. We are available for any questions or concerns you may have.
Medical Director:
Marco A. Renazco, MD
Clinical Coordinator:
Keanan Beierle PA-C
Administrative Coordinator:
Melanie W. Renazco, J.D.
Phone number:
281-599-3313
Clinic Address:
24215 Kingsland Boulevard
Katy, TX 77494
/